Financial Analyst Summary: RPG Life Sciences NSE Volume Query Response
Date and Nature of Query:
The company received a communication from the National Stock Exchange of India Ltd. (NSE) on June 11, 2026, referenced under NSE/CM/Surveillance/17084. The query sought clarification regarding an observed increase in the trading volume of the company's shares.
Company's Clarification on Trading Volume:
RPG Life Sciences, through its Head – Legal & Company Secretary Rajesh Ramesh Shirambekar, provided a formal response on June 12, 2026. The company clarified that it is not aware of any specific reason for the recent increase in trading volume. It attributed the movement purely to general market conditions, stating there was no company-specific catalyst.
Regulatory Compliance Reference:
The response explicitly confirms the company's compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company stated that all information required to be disclosed under this regulation has been duly disclosed from time to time.
Details on Undisclosed Information:
The company definitively stated that there is no unpublished event, information, or announcement relating to the operation or performance of the company that is required to be disclosed to the stock exchanges. It confirmed that no such information exists that may have a bearing on the price or volume of the company's shares.
Topic Tags: Regulatory Response, Stock Trading, Volume Increase, Compliance, SEBI LODR